Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/7559
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShah, Viral-
dc.date.accessioned2017-06-17T08:49:09Z-
dc.date.available2017-06-17T08:49:09Z-
dc.date.issued2016-05-
dc.identifier.urihttp://hdl.handle.net/123456789/7559-
dc.description.abstractCOX-2 inhibitors have been shown to interact with gastrointestinal, renal, andcardiovascular systems. They could delay ulcer healing,compromise the glomerular filtration rate, and may cause peripheral oedema and hypertension. They also cause bleeding and could promote a prothrombotic state and explain the observed increased cardiovascular risk. Finally ischemic preconditioning mechanism .Thus structural modifications are required and to get these structural modification there are so many new strategies and new methods were developed and one of the main significant change is to convert the free carboxylic group of NSAIDs into various acid derivatives.These changes lead to more selectivity and having less toxicity. In this study according molecular docking studies of designed compounds were done using cebyl for Mefenamic acid. Synthesis using DCC/DMAP,HATU/DIPEA,Pyridine/POCl3 coupling using different primary amines coupling was done. In-vivo screening of compounds with are JSAMA, JSNAP,JS_35DCA showed maximum inhibition.en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPDR00436;-
dc.subjectDissertation Reporten_US
dc.subjectPharmaceutical Chemistryen_US
dc.subject13MPHen_US
dc.subject13MPH406en_US
dc.subjectPDR00436en_US
dc.titleDesign and Synthesis of Heterocyclic Molecules as Anti- Inflammatory Agentsen_US
dc.typeDissertationen_US
Appears in Collections:M.Pharm. Research Reports, Department of Medicinal Chemistry

Files in This Item:
File Description SizeFormat 
PDR00436.pdfPDR004361.38 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.